UA101609C2 - Modified polypeptides of activin receptor and using thereof - Google Patents

Modified polypeptides of activin receptor and using thereof

Info

Publication number
UA101609C2
UA101609C2 UAA200910064A UAA200910064A UA101609C2 UA 101609 C2 UA101609 C2 UA 101609C2 UA A200910064 A UAA200910064 A UA A200910064A UA A200910064 A UAA200910064 A UA A200910064A UA 101609 C2 UA101609 C2 UA 101609C2
Authority
UA
Ukraine
Prior art keywords
activin
receptor
modified polypeptides
activin receptor
myostatine
Prior art date
Application number
UAA200910064A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Йонгхун Сан
Ли-тинг Тони Там
ХКью Хан
Кэйс Су-нюнг Квак
Ксяолан Жоу
Original Assignee
Амджен Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амджен Инк. filed Critical Амджен Инк.
Priority claimed from PCT/US2008/003119 external-priority patent/WO2008109167A2/en
Publication of UA101609C2 publication Critical patent/UA101609C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to isolated proteins of soluble receptor activin IIB, able to bind activin A receptor, myostatine or GDF-11, and to inhibit activity thereof. The invention also relates to vector and host cell, composition containing isolated protein, and to the method for treatment of amyotrophy and other diseases and defects connected with activin A receptor, myostatine or GDF-11.
UAA200910064A 2007-03-06 2008-03-06 Modified polypeptides of activin receptor and using thereof UA101609C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90545907P 2007-03-06 2007-03-06
PCT/US2008/003119 WO2008109167A2 (en) 2007-03-06 2008-03-06 Variant activin receptor polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
UA101609C2 true UA101609C2 (en) 2013-04-25

Family

ID=42556778

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200910064A UA101609C2 (en) 2007-03-06 2008-03-06 Modified polypeptides of activin receptor and using thereof

Country Status (2)

Country Link
UA (1) UA101609C2 (en)
ZA (1) ZA200906169B (en)

Also Published As

Publication number Publication date
ZA200906169B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
UA113712C2 (en) FAP ANTIBODY AND METHODS OF ITS APPLICATION
WO2008133722A3 (en) Anti human sclerostin antibodies
NZ602634A (en) Vista regulatory t cell mediator protein, vista binding agents and use thereof
EA201001223A1 (en) STABILIZED PROTEIN COMPOSITIONS
WO2010034032A3 (en) Methods for preparing purified polypeptide compositions
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
PH12015501848A1 (en) Binding agents
WO2006125962A3 (en) T cell receptors which specifically bind to vygfvracl-hla-a24
WO2006103666A3 (en) Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis
MX2010000196A (en) Prevention of disulfide bond reduction during recombinant production of polypeptides.
EP2354224A4 (en) Novel protein having fructosyl valyl histidine oxidase activity and modified product thereof, and use of the protein or the modified product
EP3578568A3 (en) Cxcr2 binding polypeptides
UA99339C2 (en) Antibody that specifically binds to human tyrp1
EA200970810A1 (en) MODIFIED ACTIVIN RECEPTOR POLYPEPTIDES AND THEIR APPLICATION
NZ598524A (en) Therapeutic dll4 binding proteins
WO2010132370A3 (en) Soluble tlt-1 for the treatment and diagnosis of sepsis
WO2009036448A3 (en) Natriuretic peptide receptor-c agonists
WO2009058957A3 (en) Intranasal administration of active agents to the central nervous system
IN2012DN02981A (en)
MX2009010492A (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells.
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
NZ603196A (en) Methods of use of soluble cd24 for therapy of rheumatoid arthritis
WO2011087795A3 (en) Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
WO2011116212A3 (en) Bone morphogenetic protein receptor binding agents and methods of their use